Skip to main content

Table 4 Ultrasound of liver at 6 months follow up post-implementation of measures to achieve glycemic control in patients with hyperechogenic liver and/or hepatomegaly

From: Prevalence of hepatopathy in type 1 diabetic children

Hepatomegaly group

At baseline

At 6 months follow up

Patient

Insulin (U/kg/d) HbA1C%

Insulin (U/kg/d) HbA1C% U/S liver

1

0.8

12

0.70

8.7

Normal

2*

0.5

10

0.75

11

Mild hepatomegaly

3

0.86

8.9

0.7

7.4

Normal

4*

0.59

7.4

0.5

8

Mild hepatomegaly

5

0.66

10.8

0.75

7.2

Normal

6

1

12.5

0.8

7.5

Normal

7*

0.62

8.1

0.7

8.8

Mild hepatomegaly

8*

0.88

8.9

0.8

9.5

Mild hepatomegaly

9

0.86

7

0.65

6.5

Normal

10

1.12

8.5

0.7

6.8

Normal

Hyperechogenic liver group

Patient

     

1

0.73

11.6

0.85

8.8

Normal

2

0.48

13.6

0.7

8.2

Normal

3‡

0.69

10.6

0.8

7.5

Normal

4*

0.5

13

0.75

12.4

hyperechogenic liver

5‡

0.87

12.3

0.85

7.4

Normal

6*

0.6

14.5

0.9

13

hyperechogenic liver

7

0.55

12.7

0.75

9

Normal

8

0.64

9.1

0.70

8.2

Normal

9‡ ¶

0.46

14.1

0.75

10.5

hyperechogenic liver

10‡ ¶

0.75

13

0.90

9.8

hyperechogenic liver

11

0.72

13

0.80

8.8

Normal

12*

0.46

8.2

0.65

10.5

hyperechogenic liver

  1. ‡: patient with celiac disease; *: Non-adherent to diabetic diet; ¶: Non-adherent to gluten free diet.